The effects of NMS and HFS were generally additive in terms of NAFLD, hepatic Cd36 mRNA levels, and hepatic Cd36 promoter DNA hypomethylation. This evidence concerns the gene CD36 and metabolic dysfunction-associated steatotic liver disease.